Lactose (India) Limited confirmed that its Scheme of Amalgamation with Vitanosh Ingredients Private Limited became operative on September 5, 2026. The consolidation follows regulatory approvals and filing requirements under the Companies Act, 2013.

The Hon'ble National Company Law Tribunal, Ahmedabad Bench, approved the Scheme vide order dated August 20, 2026. Lactose (India) Limited and Vitanosh Ingredients Private Limited filed the certified copy of this order with their respective jurisdictional Registrar of Companies on September 5, 2026.

Regulatory Compliance

This disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015. The Scheme operates under Sections 230-232 of the Companies Act, 2013.

Vitanosh Ingredients Private Limited is designated as the Transferor Company, while Lactose (India) Limited serves as the Transferee Company. The amalgamation affects the respective shareholders of both entities.

Effective Date

The Scheme became effective from September 5, 2026. This date marks the formal integration of the two entities as per Clause 18.2 of Section III of the Scheme of Amalgamation.

Ritesh Pandey, Company Secretary of Lactose (India) Limited, signed the disclosure on September 5, 2026, from Mumbai.

Lactose (India) Limited re-appointed M/s. AMS & Co. LLP as internal auditors and appointed Alpesh A. Lakeshri as cost auditor for FY27 during its board meeting on August 25, 2026.

The board also approved the draft notice for its 35th Annual General Meeting and the Director's Report for FY26. The meeting, held in Mumbai from 4:00 pm to 5:00 pm, covered statutory matters including the resignation of the previous cost auditor.

Key Board Approvals

The board finalized several administrative appointments for the upcoming financial year.

Auditor Appointments and Resignations

The board noted the resignation of M/s. Kirit Mehta & Co., Cost Accountants, as cost auditors. Consequently, it appointed Alpesh A. Lakeshri as the cost auditor for the financial year 2026-2027.

Alpesh A. Lakeshri qualified as a CMA in June 2022 and started his practice in August 2023. Before founding his firm, he spent nearly four and a half years with Kirit Mehta & Company, supervising multiple cost audit teams. He currently serves as Cost Auditor for several companies, including Piramal Pharma Limited, SeQuent Scientific Limited, and Jgsonpal Pharmaceuticals Limited.

For internal audits, the company re-appointed M/s. AMS & Co. LLP, Chartered Accountants, for FY26-27. Established in 2010, AMS & Co. is a peer-reviewed firm empaneled with the Reserve Bank of India, serving more than 150 client groups.

Governance and Remuneration

The board approved the remuneration of Mr. Atul Maheshwari, Managing Director, and Mrs. Sangita Maheshwari, Whole Time Director. It also approved the re-appointment of a director retiring by rotation.

Additionally, the board approved the Secretarial Audit Report, Internal Audit Report for FY25-26, and the Internal Audit Report for the first quarter ended June 30, 2026. The Cost Audit Report for FY25-26 was also approved.